RETRACTED: Analysis of Infertility Factors Caused by Gynecological Chronic Pelvic Inflammation Disease Based on Multivariate Regression Analysis of Logistic (Retracted Article)

被引:1
作者
Liu, Linmei [1 ]
Yang, Gang [2 ]
Ren, Jigang [1 ]
Zhang, Limei [1 ]
Wu, Ting [1 ]
Zheng, Qiao [1 ]
机构
[1] North Sichuan Med Coll, Dept Tradit Chinese Med, Affiliated Hosp, Nanchong 637000, Jiangxi, Peoples R China
[2] North Sichuan Med Coll, Dept Hepatobiliary Surg, Affiliated Hosp, Nanchong 637000, Jiangxi, Peoples R China
关键词
D O I
10.1155/2022/7531190
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
In order to solve the complex and recurrent problem of chronic pelvic inflammation disease (CPID) in the process of the clinical treatment, a method of understanding the influencing factors of CPID by investigating the actual situation of clinical cases and using logistics regression analysis was proposed in this study. A total of 204 outpatients were selected from a certain hospital. The ratio of the cases in the experimental group to those in the control group stands at 1 : 1. The results were obtained as follows. According to the data of CPID patients collected in the paper, the majority of patients had a high school education background or below technical secondary school education background, accounting for 66.7%. And the majority of patients were manual workers, accounting for 69.1%. All the exp (B) values of the frequency of sex life per month >= 9 times, frequent sex life during menstruation, IUD contraception, no contraception, abortion >= 3 times, vaginal irrigation per week >= 1 time, and intrauterine surgery >= 3 times were more than 1. These seven factors were the risk factors for chronic pelvic inflammation. Oral contraceptives were a weak protective factor of chronic pelvic inflammation. These factors including early drug withdrawal (53.1%), without understanding the condition of the disease (35.7%), no time to review the disease (24.5%), and irregular medication (21.4%) accounted for a large proportion. They were associated with the recurrence of CPID. This method is aimed at providing some foundations for establishing effective prevention and control measures for chronic pelvic inflammation and providing a recognized clinical diagnosis and efficacy evaluation criteria for the treatment of chronic pelvic inflammation.
引用
收藏
页数:7
相关论文
共 22 条
  • [1] Ahmad G., 2020, INT J RES PHARM SCI, V11, P7634, DOI [10.26452/ijrps.v11i4.4138, DOI 10.26452/IJRPS.V11I4.4138]
  • [2] Balla F., 2020, ROMANIAN J MEDICAL P, V15, P307, DOI [10.37897/RJMP.2020.3.9, DOI 10.37897/RJMP.2020.3.9]
  • [3] Experimental, computational analysis of Butein and Lanceoletin for natural dye-sensitized solar cells and stabilizing efficiency by IoT
    Bradha, M.
    Balakrishnan, Nagaraj
    Suvitha, A.
    Arumanayagam, T.
    Rekha, M.
    Vivek, P.
    Ajay, P.
    Sangeetha, V
    Steephen, Ananth
    [J]. ENVIRONMENT DEVELOPMENT AND SUSTAINABILITY, 2022, 24 (06) : 8807 - 8822
  • [4] Univariate and multivariate sex dimorphism in the diverse age group of the South Indian dentition using the polyvinyl siloxane elastomeric impression material
    Chaudhary, Roshan Kumar
    Doggalli, Nagabhushana
    Subedi, Nuwadatta
    [J]. EGYPTIAN JOURNAL OF FORENSIC SCIENCES, 2021, 11 (01)
  • [5] Fuke Qianjin Combined with Antibiotic Therapy for Pelvic Inflammatory Disease: A Systematic Review and Meta-Analysis
    Chen, Yu
    Wei, Shaobin
    Huang, Li
    Luo, Mei
    Wu, Yang
    Yin, Caimmiao
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [6] Clinical cure rate of pelvic inflammatory disease. Should ceftriaxone be part of the first line regimen?
    Dabis, Rasha
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2020, 31 (14) : 1432 - 1433
  • [7] Fathurahman M., 2020, ABSTR APPL ANAL, V2020, P10, DOI [10.1155/2020/8353481, DOI 10.1155/2020/8353481]
  • [8] Knowledge map visualization of technology hotspots and development trends in China's textile manufacturing industry
    Huang, Ruihang
    Yan, Ping
    Yang, Xiaoming
    [J]. IET COLLABORATIVE INTELLIGENT MANUFACTURING, 2021, 3 (03) : 243 - 251
  • [9] Jing D., 2020, DIGIT CHIN MED, V3, P213, DOI [10.1016/j.dcmed.2020.09.007, DOI 10.1016/J.DCMED.2020.09.007]
  • [10] Kale P.A., 2020, J SAFOMS, V8, P24, DOI [10.5005/jp-journals-10032-1204, DOI 10.5005/JP-JOURNALS-10032-1204]